Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer
(Q35117571)
scientific article published on April 1, 2003
scientific article published on April 1, 2003
Language:
Current Data About
Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P304) |
30-33
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
2 Suppl 3
|
||||||||||||||||
| (P478) |
30
|
||||||||||||||||
| (P577) |
Tuesday, April 1, 2003
|
||||||||||||||||
| (P921) |
(Q162555)
|
||||||||||||||||
| (P1433) |
(Q14330412)
|
||||||||||||||||
| (P1476) |
"Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer" (language: en)
"Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer" (language: en)
|
||||||||||||||||
| (P2093) |
Debasish Roychowdhury
Michael Lahn
|
||||||||||||||||
| (P13046) |
(Q7318358)
|
other details
| description | scientific article published on April 1, 2003 |
External Links
| (P356) |
10.1053/SONC.2003.37273
|
| (P698) |
12722024
|